BioLineRx Ltd. (NASDAQ:BLRX) Q1 2023 Earnings Call Transcript

BioLineRx Ltd. (NASDAQ:BLRX) Q1 2023 Earnings Call Transcript May 24, 2023

BioLineRx Ltd. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $0.14.

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2023 Financial Results Conference Call. [Operator Instructions] I’d now like to turn over the call to John Lacey, Head of Investor Relations and Corporate Communications BioLineRx. Please go ahead.

John Lacey: Thank you,...